#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Skin cancer Dementia Alzheimer's type Hypoxic-ischaemic encephalopathy Malignant central nervous system neoplasm Partial lipodystrophy Breast cancer metastatic Immune-mediated myasthenia gravis Leukocyte adhesion deficiency type I Mucopolysaccharidosis III Epidermolysis bullosa Prostate cancer Nephropathy Mantle cell lymphoma stage IV Autoimmune demyelinating disease Burkitt's lymphoma refractory More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma Glomerulonephritis membranous – Life with Disease Behcet’s syndrome Mantle cell lymphoma stage III Congenital nephrogenic diabetes insipidus – Basic Information Hereditary angioedema – Life with Disease Langerhans’ cell histiocytosis – Life with Disease Focal segmental glomerulosclerosis – Basic Information Cerebral arteriovenous malformation haemorrhagic – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Chloride Solution 0.9% Antithrombin Iii Human L-Glutamic Acid Dolutegravir Sodium Saxagliptin FRUQUINTINIB VX-993 BENZYDAMINE HYDROCHLORIDE Rimegepant METHYLPHENIDATE Thiopental Sodium Ulipristal Acetate Paclitaxel Albumin-Bound Radium Ra 223 Dichloride Pimecrolimus Gtaexs617 Lurbinectedin Ociperlimab Oric-114 Setanaxib More therapies…

    Learn about Your Condition

    Foetal growth restriction Neuralgia Oesophageal adenocarcinoma Ocular hypertension Pulmonary vascular disorder Rhabdoid tumour Dementia Bone marrow failure Mental disorder Colour blindness Acarodermatitis Rectal cancer stage II Muscular dystrophy Vertigo Skin cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Effects of Dexmedetomidine on Neuroinflammation in COVID-19 ARDS Survivors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Dexmedetomidine
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study on the Effectiveness of Human Hepatitis B Immunoglobulin for Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Human Hepatitis B Immunoglobulin
    Germany

  • Study of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Tenofovir Disoproxil
    Romania

  • Study of Vericiguat to improve physical function in patients with Post-COVID-19 syndrome with or without chronic fatigue syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Vericiguat
    Germany

  • Study on Switching from Boosted Protease Inhibitors to Fostemsavir for People with HIV-1 with Limited Treatment Options

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Fostemsavir Trometamol
    Italy Spain

  • Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3
Previous Page
1 … 38 39 40 41 42 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!